31.1 C
Delhi
Friday, June 2, 2023

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

Share post:

Los Angeles: Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Arrest Brij Bhushan Singh or we will go to Jantar Mantar on June 9: Rakesh Tikait

On Friday, 2nd June, farmers’ leader, Rakesh Tikait, said that the government must arrest former WFI Chief Brij...

Stalin releases logo to mark Karuna’s year long birth centenary fete

Chennai: Tamil Nadu Chief Minister and DMK President M.K.Stalin today formally launched the year long birth centenary celebrations...

Brij Bhushan postpones his Jan Chetna Maharally

Lucknow: Former president of Wrestling Federation of India (WFI) and Bharatiya Janata Party (BJP) MP from Kaisarganj Brij...

56 passengers injured as HRTC bus crashes to hill

Shimla: A Himachal Road Transport Corporation (HRTC) bus met with a mishap at Barsheel area of sub-Division Rohru...